You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創業慧康(300451.SZ):擬與飛利浦(中國)進行商業合作
格隆匯 06-30 19:33

格隆匯6月30日丨創業慧康(300451.SZ)公佈,根據公司業務發展的需求,公司擬與飛利浦(中國)投資有限公司(“飛利浦(中國)”)進行商業合作,共同拓展醫院信息化軟件的中國市場,公司將向飛利浦(中國)購買“Tasy軟件”中國區域獨家許可權,雙方將在合作期限內基於“Tasy軟件”進行本地化開發,並依託前述公司本地化開發的“新一代EMR軟件”在中國市場共同推進商業戰略合作。

公司引入“Tasy軟件”的領先技術和理念,通過本地化的開發,將向中國醫療機構推出“新一代EMR軟件產品”,新產品與傳統的HIS/EMR/集成平台醫院核心系統三件套解決方案不同,將能夠為醫療機構提供一個一體化的平台,能夠涵蓋所有護理場景的集成解決方案,成功地實現臨牀、組織和管理流程的集中管理,實現更先進的臨牀分析,更好地簡化醫院的工作流程,提高護理質量和效率,保障患者安全。另外,一體化解決方案也降低了平時的運維成本,降低了醫療機構信息化認證的難度,並提供了後續業務應用擴展的關鍵支撐。

飛利浦是全球領先的醫療健康IT公司之一,在結構化臨牀數據庫、影像流程管理、智能圖像存儲及後處理、精準診斷輔助決策、患者數據中央站、慢病管理、家庭護理等各個臨牀場景,擁有豐富的數字化和信息學解決方案。此次雙方的戰略合作將在市場、運營、研發、管理等多方面給公司帶來積極影響。有利於構建公司多元化的董事會及股權結構,提高上市公司的治理水平。此次協議的簽署,將推動雙方發揮各自優勢,增強公司在市場拓展及產品創新能力,提升公司在醫療衞生信息化領域的核心競爭力。同時,與業界企業開展多維度的合作,實現橫向擴展縱向聯動,將加速推進公司的“慧康雲”戰略,實力推動行業生態模式轉化、客户生態羣重構。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account